Revvity Corp (RVTY) Price to Earnings Ratio

Corporate emblem and logo of PerkinElmer (RVTY)

The Revvity, Inc. (RVTY) P/E chart helps track cyclical shifts during periods of stagnation, while the 68.70 value captures the metric level. Revvity, Inc. (RVTY) exhibits moderate cyclicality, as equipment procurement depends on interest rates and seasonal institutional spending. Strong pricing power is based on inelastic demand for reagents and software. A balanced structure relies on high-margin IT solutions and prenatal diagnostics.

RVTY Revvity: Price to Earnings Ratio in the range 02/21/2024 - 11/11/2026
Manufactured product of Revvity, Inc.

Assessing the asset quality of Revvity, Inc. (RVTY) requires an analysis of the ratio of market capitalization to net income. The current P/E multiple measures the investment payback period, reflecting market expectations regarding future cash flows. For this company, the low demand elasticity for diagnostic software and reagents ensures stable margins. Such pricing power minimizes the risk of overpaying for the business, confirming the fundamental stability of its capital.

Key competitors

P/E Multiple agilent.com|Price to Earnings Ratio Quest Diagnostics Incorporated (DGX)|Price to Earnings Ratio ILMN (Illumina Inc)|Cologuard - Price to Earnings Ratio|Bio-Rad Corp (BIO) - Market Cap to Earnings|NNNN - Price to Earnings Ratio|Business Payback Period soterahealth.com SHC|QDEL: P/E Multiple|OPK - Business Payback Period|Price to Earnings Ratio CareDx, Inc|Maravai (MRVI) - Business Payback Period|Price to Earnings Ratio Fulgent Genetics, Inc. (FLGT)|LAB (fluidigm.com) - Company Value to Net Income|P/E Multiple CTKB (Cytek Biosciences)|OraSure Technologies, Inc. (OSUR) - Market Cap to Earnings|XGN: Price to Earnings Ratio|MDXH: Price to Earnings Ratio|LUCD (Lucid Diagnostics Inc.) - Price to Earnings Ratio|PRE (Prenetics) - Price to Earnings Ratio|IMDX (Insight Molecular Diagnostics, Inc.) - P/E Multiple|Trinity Biotech Corp (TRIB) - Business Payback Period|Price to Earnings Ratio PRPH (ProPhase)|Market Price to Net Income Ratio AIMD|Co-Diagnostics, Inc. - Price to Earnings Ratio|heartsciences.com (HSCS) - Market Cap to Earnings|BMRA: Price to Earnings Ratio|Company Value to Net Income CDIO (Cardio Diagnostics)|ONCO: P/E Multiple|VRAX - Business Payback Period|Price to Earnings Ratio Bluejay Diagnostics|Price to Earnings Multiple AWH (aspirawh.com)|P/E Multiple AXDX|Price to Earnings Ratio CENTOGENE CNTG|Enzo Biochem - Price to Earnings Ratio|Business Payback Period Fresh2 Group Ltd (FRES)|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andme.com)|PMD (Psychemedics Corporation) - Price to Earnings Ratio